Refer a Patient
Interactive Medicine


Professor Barclay is actively involved in a range of research projects in both Gastroenterology and Clinical Pharmacology, with collaborators in New Zealand, Australia, Europe and the United Kingdom. He has been awarded the University of Otago Christchurch Gold Medal for research.

Main Areas of Research:

Inflammatory Bowel Disease
  • Causes
  • Epidemiology
  • Genetics
  • Drug Therapy

  • How our genetic makeup affects how well a drug works and what side effects might occur

Immunomodulator drugs
  • Thiopurines and methotrexate, used to treat immune diseases like Inflammatory Bowel Disease and Rheumatoid Arthritis

Monoclonal antibody drugs
  • Infliximab and adalimumab are antibody drugs against tumour necrosis factor and are used in inflammatory bowel disease and other autoimmune diseases.

  • Publications